| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |